Ibogaine: A Controversial Path to Healing
Ibogaine is gaining attention as a potential treatment for PTSD, but its journey remains fraught with challenges.
Tag: FDA
Eye drop: K.C. Pharmaceuticals’ Recall: A Serious Concern
K.C. Pharmaceuticals has initiated a significant recall of eye drops due to sterility issues, affecting millions of bottles across major retailers.
MEDVi’s Surge Amid Tirzepatide Market Changes
MEDVi is experiencing rapid growth as the tirzepatide drug shortage resolves, positioning itself as a leader in telehealth weight loss solutions.